Carol Whelan

Dr Carol Whelan was appointed as Consultant Cardiologist with an interest in imaging, heart failure and, in particular, cardiac amyloidosis, in October 2009 at the Royal Free London NHS Foundation Trust. She was appointed as Honorary Associate Professor at UCL in recognition for her work at the National Amyloidosis Centre.
She was appointed as Trust lead for heart failure and chairs a weekly cross site meeting of the dedicated Heart Failure Clinical Pathways Group. Through the CPG, the team aims to harmonise the experience for patients with heart failure to achieve excellence in a quality service across the Trust.
In November 2019, Dr Whelan was appointed as councillor on the board of the British Society for Heart Failure. She wrote the chapter on cardiac amyloidosis in the latest Oxford Textbook of Heart Failure and has published widely on this subject.
As a clinical expert, she assisted the NICE committee in their evaluation of two novel treatments, inotersen and patisiran, for hereditary transthyretin amyloidosis. These have both been approved in the UK.